Where does Jilin Cofco Biomaterial Co., Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Jilin Cofco Biomaterial Co., Ltd ranks #47,965 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Jilin Cofco Biomaterial Co., Ltd hold?

Jilin Cofco Biomaterial Co., Ltd holds 5 US utility patents granted between 2021 and 2021, spanning 10 technology areas.

What is Jilin Cofco Biomaterial Co., Ltd's Innovation Score?

Jilin Cofco Biomaterial Co., Ltd has an Innovation Score of 23.9 out of 100 (13th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Jilin Cofco Biomaterial Co., Ltd's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Jilin Cofco Biomaterial Co., Ltd.

What does claim depth mean for Jilin Cofco Biomaterial Co., Ltd's patents?

Jilin Cofco Biomaterial Co., Ltd's patents average 10.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Jilin Cofco Biomaterial Co., Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Jilin Cofco Biomaterial Co., Ltd

Q: What technology areas does Jilin Cofco Biomaterial Co., Ltd focus on?

Jilin Cofco Biomaterial Co., Ltd's top technology area is C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds) with 4 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 10 technology areas, recorded in grant years 2021–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Jilin ranks #47,965 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 10 technology areas.

#47,965
of 49,997 US assignees by volume: 13th percentile
by Innovation Score (23.9/100): 10.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R47965 · Foreign Corporation #47,965 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #47,965/49,997
PHOTO-FINISH Jiangxi Rare Earth…
CPC-FOCUS C08G · 10 areas
INNOV-THIN 23.9/100
CLAIMS-PAR 10.8 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2021 · 1y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Jiangxi Rare Earth and Rare Metals Tungsten Group Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Jilin Cofco… · this assignee

24
3D Lighting… · lowest

7

What this shows Jilin's Innovation Score is 23.9/100 (13th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Jilin's grants concentrate

Jilin Cofco Biomaterial Co., Ltd is a focused PatentsView assignee: 10 CPC subclasses with 80% of grants classified under C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds). By volume, Jilin sits between Jiangxi Rare Earth and Rare Metals Tungsten Group Corporation and Jinlong Industrial Co., Ltd..

Jiangxi Rare Eart…

5
Jiangyin Sinbon

5
Jiaxing Explorer…

5
Jikai Biosciences

5
Jinlong Machinery…

5
Jingle

5
Jingzhou Jiahua T…

5
Jinlong Industrial

5
Jilin Cofco Bioma… ◀

5

What this shows Jilin holds 5 patents at rank #48,014, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Jilin

By rank, the assignees closest to #48,014 in granted patent volume.

Leaders in C08G (Macromolecular Compounds Obtained Otherwise Than BY React…)

Other assignees with the most granted patents in Jilin's primary technology class.

Jilin's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 13th percentile higher than 13% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Jilin Cofco Biomaterial Co., Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	5	100.0%

Which technologies does Jilin Cofco Biomaterial Co., Ltd patent most?

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 4

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 4

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

C08L - Compositions OF Macromolecular Compounds 1

B29B - Preparation OR Pretreatment OF THE Material TO BE SHAPED; Making Granules OR PREFORMS; Recovery OF Plastics OR Other Constituents OF Waste Material Containing Plastics 1

B01D - Separation 1

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#47,965

of 49,997 tracked assignees

Innovation Score

23.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Jilin Cofco Biomaterial Co., Ltd's patent record in context - here's where to go next.

Jilin Cofco Biomaterial Co., Ltd's lead technology class is C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds), 80% of its portfolio - see every assignee active in that class. Explore C08G
Ranked #47,965 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Jilin Cofco Biomaterial Co., Ltd against Jiangxi Rare Earth and Rare Metals Tungsten Group Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 23.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.